Researchers from Melbourne's Peter MacCallum Cancer Centre have been trialling IBM's Watson artificial intelligence technology to see if they can better match cancer patients to relevant clinical trials.

In a recent retrospective study, the Peter Mac researchers used past records of 102 lung cancer patients and matched each patient to 10 potential trials using IBM Watson for Clinical Trial Matching, which helps optimise trial recruitment at the point of care.